Exchange: OTC·Updated 02:56 PM EDT

ATGN News

News
all
press releases
Top Analyst Reports for Taiwan Semiconductor, Johnson & Johnson and Palantir
Taiwan Semiconductor, Johnson & Johnson and Palantir headline today's analyst reports, with AI growth, drug pipelines and competitive pressures shaping their outlooks.
Zacks
Top Analyst Reports for Taiwan Semiconductor, Johnson & Johnson and Palantir
Taiwan Semiconductor, Johnson & Johnson and Palantir headline today's analyst reports, with AI growth, drug pipelines and competitive pressures shaping their outlooks.
Zacks
More News
OPTX and ATGN are in high growth verticals.
Zacks
Top research reports spotlight Visa as payments grow, Lam Research on AI demand and Caterpillar on strong backlog.
Zacks
Visa's payments growth, Lam Research's AI-driven demand and Caterpillar's broad market momentum headline today's top analyst reports.
Zacks
Altigen's fiscal Q3 earnings per share remain flat year over year as cloud services weaken, while a lower gross margin adds pressure, partly offset by reduced operating expenses.
Zacks
ATGN's AI-driven CXaaS transformation, higher recurring revenue, strategic partnerships and scalable operations position the company for accelerating growth and improving profitability.
Zacks
Altigen posts fiscal Q2 EPS of 1 cent, with a shift toward AI-powered CXaaS solutions but faces lower cloud revenue.
Zacks
Meta's AI push lifts engagement, Netflix eyes revenue doubling by 2030, and Pfizer leans on new launches to offset looming patent cliffs.
Zacks
Meta Platforms, Netflix and Pfizer lead fresh research as AI bets, bold 2030 goals and patent cliffs shape their outlooks.
Zacks
Altigen's fiscal Q1 results face revenue decline from legacy platform transition, but strong margins, cost control and upcoming AI launches signal potential growth in the second half of FY2026.
Zacks

Advertisement|Remove ads.